Udayavni Special

Bharat Biotech’s Covaxin 81 pc efficient in Phase 3 trials


PTI, Mar 3, 2021, 7:25 PM IST

New Delhi: Vaccine major Bharat Biotech on Wednesday said its COVID-19 vaccine, Covaxin, has demonstrated an interim vaccine efficacy of 81 per cent in Phase 3 clinical trials.

The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research, the Hyderabad-based company said in a statement.

”Today is an important milestone in vaccine discovery, for science and our fight against coronavirus. With today’s results from our Phase 3 clinical trials, we have now reported data on our COVID-19 vaccine from Phase 1, 2, and 3 trials involving around 27,000 participants,” Bharat Biotech Chairman and Managing Director Krishna Ella said.

Covaxin demonstrates a high clinical efficacy trend against COVID-19 but also significant immunogenicity against the rapidly emerging variants, he added.

Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Covaxin and Oxford-AstraZeneca’s Covishield are the two vaccines that are being administered in the country.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

India closer to building world’s biggest nuclear plant: EDF

States must jointly negotiate uniform Covid-19 vaccine price with manufacturers, says Chidambaram

BSY urges PM to supply 1,471 tonnes of oxygen and two lakh doses of Remdesivir

IAF airlifts empty oxygen containers to filling stations across India

Rahul raises questions on govt’s priorities after bids invited for central vista project

More data confirms single dose of 2 Covid vaccines can cut risk of infection

Norwegian climber 1st to test positive on Mount Everest




Related Articles More

Delhi puts in request for ”Oxygen Express”; demand likely to be met from Rourkela

Bihar’s ”oxygen man” ray of hope for critical COVID-19 patients

India’s COVID-19 graph may peak at 33-35 lakh active cases by May 15, say IIT scientists

TN CM writes to Modi, seeks 20 lakh doses of Covid vaccine from Centre

Govt issues revised clinical guidance for management of COVID-19 patients

MUST WATCH

Udayavani 23-April-2021 News Bulletin

D.K. district administration will be able to deal with the situation adequately for the next 15 days: Dr. Rajendra K.V

Mangaluru: 1 arrested in Surathkal animal cruelty case

Saligrama town Panchayat Dumping Yard protest

Fire broke out at Mangaluru Catholic Co-operative Bank

Latest Additions

Airlift oxygen, give adequate vaccines, allow Remdesivir imports: Thackeray tells PM

Would have taken part in COVID meeting between PM Modi, CMs had I been invited: Mamata

India closer to building world’s biggest nuclear plant: EDF

States must jointly negotiate uniform Covid-19 vaccine price with manufacturers, says Chidambaram

Mangaluru Police arrest history sheeter for conspiring to commit robbery, murder

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.